» Articles » PMID: 39719503

Associations Between Shorter Leucocyte Telomere Length and Increased Risk of Age-related Macular Degeneration in Women: Insights from the United Kingdom Biobank Study

Overview
Journal Eye (Lond)
Specialty Ophthalmology
Date 2024 Dec 24
PMID 39719503
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine the association between telomere length (TL) and age-related macular degeneration (AMD) and examine the potential variations with sex and ethnicity.

Methods: Population-based, cross-sectional study. A total of 52,083 participants from the UK Biobank were included. Leucocyte TL, measured using quantitative polymerase chain reaction assay, was presented as the ratio of telomere repeat copy number relative to that of a single copy gene, and then log-transformed and Z-standardised. AMD cases were identified based on a combination of in-patient, self-reported and primary care data, and furtherly classified as early, intermediate and late AMD using the Beckmann classification system (based on more severe eye).

Results: Among the 52,083 participants aged 60.2 ± 5.4 years, 725 were any-AMD cases. AMD patients had shorter TL than those without AMD (-0.22 ± 0.95 vs. -0.10 ± 0.99, P = 0.001). In multivariable model, shorter TL (per standard deviation) was significantly associated with higher odds of AMD in Whites (OR:1.09; 95% CI: 1.01-1.18; P = 0.036). When stratified by sex and ethnicity, this association was only significant in White women (OR:1.14; 95%CI: 1.02, 1.27; P = 0.018), but not in men and nonwhite populations (all P ≥ 0.335). Among white women, the association was more pronounced (OR:1.47; 95%CI:1.23-1.77; P < 0.001) for intermediate/late AMD but not for early AMD (P = 0.789).

Conclusions: Shorter TL was associated with any AMD in white women but not in men and other ethnicities. Our findings highlight the potential role of telomere length in the pathogenesis of AMD and the importance of considering sex and ethnicity variation in this research area.

Citing Articles

Age-related macular degeneration in 2025- opportunities and challenges.

Cheung C Eye (Lond). 2025; .

PMID: 40011740 DOI: 10.1038/s41433-025-03710-8.


Analysis of choroidal markers of activity in pachychoroid disease spectrum.

Fuganti R, Campiolo F, Mansour A, Lima L, Maia M, Casella A Graefes Arch Clin Exp Ophthalmol. 2025; .

PMID: 39849118 DOI: 10.1007/s00417-025-06740-w.

References
1.
Wong W, Su X, Li X, Cheung C, Klein R, Cheng C . Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2):e106-16. DOI: 10.1016/S2214-109X(13)70145-1. View

2.
Lambert N, Elshelmani H, Singh M, Mansergh F, Wride M, Padilla M . Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016; 54:64-102. PMC: 4992630. DOI: 10.1016/j.preteyeres.2016.04.003. View

3.
Harley C, Futcher A, Greider C . Telomeres shorten during ageing of human fibroblasts. Nature. 1990; 345(6274):458-60. DOI: 10.1038/345458a0. View

4.
Rossiello F, Jurk D, Passos J, dAdda di Fagagna F . Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022; 24(2):135-147. PMC: 8985209. DOI: 10.1038/s41556-022-00842-x. View

5.
Samani N, Boultby R, Butler R, Thompson J, Goodall A . Telomere shortening in atherosclerosis. Lancet. 2001; 358(9280):472-3. DOI: 10.1016/S0140-6736(01)05633-1. View